Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Protagonist Therapeutics Inc (NQ: PTGX )

29.35 USD +1.44 (+5.16%)
Official Closing Price Updated: 4:00 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 378,600
Open 28.02
Bid (Size) 20.00 (1)
Ask (Size) 30.26 (1)
Prev. Close 27.91
Today's Range 27.79 - 30.13
52wk Range 6.130 - 32.10
Shares Outstanding 43,808,308
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Protagonist Announces Plans to Initiate a Global Phase 3 Study for Rusfertide in Polycythemia Vera Following Interactions with the U.S. Food & Drug Administration and the European Medicines Agency
-- End-of-Phase-2 meeting with the FDA, and written comments from the EMA, support advancement of the Company's clinical development plan for rusfertide in PV -- 
From PR Newswire
Protagonist Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update
-- Regulatory guidance anticipated in the first half of 2021 for registrational clinical development plan of investigational drug, rusfertide (PTG-300), for polycythemia vera -- 
From PR Newswire

Performance

YTD
+49.74%
+49.74%
1 Month
+1.59%
+1.59%
3 Month
+24.68%
+24.68%
6 Month
+45.23%
+45.23%
1 Year
+328.47%
+328.47%

More News

Read More
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
From PR Newswire
Protagonist Therapeutics to Participate in the H.C. Wainwright Global Life Sciences Conference
From PR Newswire
Protagonist Therapeutics Reports Granting of Inducement Award
From PR Newswire
Protagonist Therapeutics to Participate in the SVB Leerink Virtual 10th Annual Global Healthcare Conference
From PR Newswire
Protagonist Therapeutics Reports Granting of Inducement Award
From PR Newswire
10 Biggest Price Target Changes For Thursday
Tags Benzinga ASAN AVEO
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tags AKER Benzinga RDHL
From Benzinga
Stocks Flashing Renewed Technical Strength: Protagonist Therapeutics
From Investor's Business Daily
Stock Upgrades: Protagonist Therapeutics Shows Rising Relative Strength
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.